Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Effect of eicosapentaenoic acid-derived prostaglandin E3 on intestinal epitelial barrier function

dc.contributor.authorRodríguez Lagunas, María José
dc.contributor.authorFerrer i Roig, Ruth
dc.contributor.authorMoreno Aznárez, Juan José
dc.date.accessioned2024-02-21T09:24:07Z
dc.date.available2024-02-21T09:24:07Z
dc.date.issued2013-05-01
dc.date.updated2024-02-21T09:24:07Z
dc.description.abstract<p>Prostaglandins (PG) are inflammatory mediators derived from arachidonic or eicosapentaenoic acid giving rise to the 2-series or the 3-series prostanoids, respectively. Previously, we have observed that PGE 2 disrupts epithelial barrier function. Considering the beneficial effect of fish oil consumption in intestinal inflammatory processes, the aim of this study was to assess the role of PGE 3 on epithelial barrier function assessed from transepithelial electrical resistance and dextran fluxes in Caco-2 cells. The results indicate that PGE 3 increased paracellular permeability (PP) to the same extent as PGE 2, through the interaction with EP 1 and EP 4 receptors and with intracellular Ca 2+ and cAMP as the downstream targets. Moreover, we observed a redistribution of tight junction proteins, occludin and claudin-4. In conclusion, PGE 3 is able to increase PP thus leading to reconsider the role of PGE 2/PGE 3 ratio in the beneficial effects of dietary fish oil supplementation in the disruption of barrier function.</p>
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec629913
dc.identifier.issn0952-3278
dc.identifier.urihttps://hdl.handle.net/2445/207865
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.plefa.2013.02.001
dc.relation.ispartofProstaglandins Leukotrienes and Essential Fatty Acids, 2013, vol. 88, num.5, p. 339-345
dc.relation.urihttps://doi.org/10.1016/j.plefa.2013.02.001
dc.rights(c) International Society for the Study of Fatty Acids and Lipids, 2013
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
dc.subject.classificationMalalties inflamatòries intestinals
dc.subject.classificationEpiteli
dc.subject.classificationCèl·lules epitelials
dc.subject.otherInflammatory bowel diseases
dc.subject.otherEpithelium
dc.subject.otherEpithelial cells
dc.titleEffect of eicosapentaenoic acid-derived prostaglandin E3 on intestinal epitelial barrier function
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
167285.pdf
Mida:
727.97 KB
Format:
Adobe Portable Document Format